Human Genome Sciences, Inc. (HGSI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Troll_29 who wrote (74)	3/4/1997 10:47:00 AM
From: Rocketman	of 1127

HGSI mainly wants to be a drug company and use the genomic info to cure diseases. They also sold off most of the rights to their info to Smith Kline before they did an IPO for $120 M. TIGR's data goes to HGSI for their support. INCY's business model is not to be a drug company, but to be a support service to the bio/pharma industry. They have over $70 M in revenue committed for 1997 and their deals are generally 3 year in duration, hence the doubling in revenue each year. This doesn't include any of the potential royalties. I don't know about MDLI.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next